David J. Borges serves as the Vice President of Finance, Chief Accounting Officer, and Treasurer at OMEROS CORP, a biopharmaceutical company focused on developing and commercializing innovative treatments for inflammation, immunologic diseases, and central nervous system disorders. In his multifaceted role, Borges is responsible for overseeing the company's financial operations, ensuring compliance with regulatory standards, and managing the treasury functions. His strategic financial leadership is crucial in supporting OMEROS's growth and development of its product pipeline. Borges brings a wealth of experience to OMEROS, having spent over two decades in the finance sector, primarily within the life sciences industry. Prior to joining OMEROS, he held significant roles at other biopharmaceutical companies, where he honed his skills in financial planning, risk management, and corporate governance. His deep understanding of the industry's financial intricacies and his ability to navigate complex regulatory environments have been instrumental in driving OMEROS's financial stability and strategic initiatives. Throughout his career, Borges has demonstrated a commitment to excellence and innovation in financial management. His contributions at OMEROS have been pivotal in securing funding for critical research and development projects, as well as in guiding the company through various stages of growth. Under his leadership, OMEROS has maintained a strong financial position, enabling the company to advance its mission of bringing transformative therapies to patients worldwide.